Panel Discussion: Totally Drug Resistant TB Is Here: Are We Too Late? || HGHI

Panel Discussion: Totally Drug Resistant TB is here: Are we too late? || HGHI – Barry Bloom, Ph.D., Harvard School of Public Health (Chair); Sarah Fortune, MD, Harvard School of Public Health; Jeremy Greene, MD, Ph.D., Harvard Medical School; Bob Horsburgh, Ph.D., Boston University; Khisimuzi Mdluli, Ph.D., TB Alliance; Scott Podolsky, MD, Harvard Medical School; Zarir Udwadia, MD, Hunduja National Hospital, Mumbai; and Rob Warren, Ph.D., Stellenbosch University, Cape Town A topical discussion to answer how we have arrived at TDR; to discuss new drugs in the pipeline; to consider the ethical and policy considerations surrounding patient treatment; to predict the spread of TDR, and to mobilize our community to devise a strategy to cure people infected with TDR TB. Sixth Annual New England Tuberculosis Symposium Harvard Global Health Institute June 28th, 2012 The Broad Institute 7 Cambridge Center Cambridge, MA

New biotech startup for therapeutic cancer vaccines includes Yervoy research …

Filed under: drug treatment centers in massachusetts

The team behind Jounce Therapeutics in Cambridge, Massachusetts includes Dr. James Allison, the man whose research led to the clinical development of Yervoy, Bristol Myers-Squibb's melanoma vaccine approved by the U.S. Food and Drug …
Read more on MedCity News

Hassan Budget Boosts Ed, Safety, Health Care

Filed under: drug treatment centers in massachusetts

And I have too often heard stories like the one told to me by a woman in Londonderry, whose daughter went to UMass Lowell because Massachusetts' out-of-state tuition is lower than New Hampshire's in-state tuition. …. This parity is smart and it is …
Read more on Patch.com